Stockreport

Anthera Pharmaceuticals Announces Receipt of Nasdaq Listing Determination Notice and Plans Appeal

ANTHERA PHARMS INC NEW  (ANTH) 
Last anthera pharms inc new earnings: 11/6 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.anthera.com/investor-relations
PDF Delisting notice was expected as part of the compliance extension previously granted by NasdaqContinue “ANTH” listing until formal hearing process is complete with the N [Read more]